Catheter Precision (VTAK) investor SEG JETS SPV I, LLC reports 9.79% ownership
Rhea-AI Filing Summary
Catheter Precision, Inc. received a Schedule 13G reporting that SEG JETS SPV I, LLC, a Delaware limited liability company, is a significant shareholder. SEG JETS SPV I, LLC reports beneficial ownership of 1,065,620 shares of common stock, with shared voting and dispositive power over all of these shares and no sole power.
This position represents 9.79% of Catheter Precision’s common stock, based on 10,880,868 shares outstanding as verified with the issuer on July 17, 2026. The filing is signed by Joseph Reda, as Manager of SEG JETS SPV I, LLC.
Positive
- None.
Negative
- None.
Key Figures
Shares beneficially owned: 1,065,620 shares
Ownership percentage: 9.79%
Shares outstanding baseline: 10,880,868 shares
+3 more
6 metrics
Shares beneficially owned
1,065,620 shares
Common stock of Catheter Precision, Inc. reported by SEG JETS SPV I, LLC
Ownership percentage
9.79%
Percent of Catheter Precision common stock class beneficially owned
Shares outstanding baseline
10,880,868 shares
Shares of common stock outstanding as verified with the issuer on July 17, 2026
Par value per share
$0.0001 per share
Par value of Catheter Precision common stock
Shared voting power
1,065,620 shares
Shares over which SEG JETS SPV I, LLC has shared power to vote
Shared dispositive power
1,065,620 shares
Shares over which SEG JETS SPV I, LLC has shared power to dispose
Key Terms
Schedule 13G, beneficially owned, shared voting power, shared dispositive power, +1 more
5 terms
Schedule 13G regulatory
"Catheter Precision, Inc. received a Schedule 13G reporting that SEG JETS SPV I, LLC"
A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.
beneficially owned financial
"Amount beneficially owned: See Item 9 on the cover pages(s) hereto."
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
percent of class financial
"Percent of class: See Item 11 on the cover page(s) hereto."
Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What stake in Catheter Precision, Inc. (VTAK) does SEG JETS SPV I, LLC report?
SEG JETS SPV I, LLC reports beneficial ownership of 1,065,620 shares of Catheter Precision common stock. This holding represents 9.79% of the outstanding shares, making it a significant minority shareholder.
How was SEG JETS SPV I, LLC’s 9.79% ownership in VTAK calculated?
The 9.79% ownership is based on 10,880,868 shares of Catheter Precision common stock outstanding. That outstanding share count was verified with the issuer on July 17, 2026, as stated in the Schedule 13G.
Who signed the Schedule 13G for Catheter Precision, Inc. (VTAK)?
The Schedule 13G is signed by Joseph Reda in the capacity of Manager of SEG JETS SPV I, LLC. The signature is dated July 20, 2026, confirming the information on behalf of the reporting person.
What addresses are listed for Catheter Precision, Inc. (VTAK) and SEG JETS SPV I, LLC?
Catheter Precision’s principal executive offices are at 1670 Highway 160 West, Suite 205, Fort Mill, SC 29708. SEG JETS SPV I, LLC’s address is 135 Sycamore Drive, Roslyn, NY 11576, as disclosed in the Schedule 13G.
What class of securities in VTAK is reported in this Schedule 13G?
The filing covers common stock of Catheter Precision, Inc., with a $0.0001 par value per share. The securities are identified by CUSIP 74933X708 in the ownership disclosure.